Dr. Éva Lívia Nagy

Dr. Éva Lívia Nagy

Home
Infectology
Immunology
Tropical Diseases - Travel Medicine
Dr. Eva Lívia Nagy, infectious disease specialist and immunologist

Dr. Éva Lívia Nagy
Infectologist, Immunologist, Tropical diseases expert

Language:
• hungarian
• english

Consultation hours:
Monday: 17:00 – 20:00
Thursday: 12:00 – 20:00
Make an appointment

Professional background

I am Dr. Éva Lívia Nagy. I obtained my general medical degree in 2012 at the Medical and Health Sciences Center of the University of Debrecen.

From 2012, I gained experience as a resident at the Szabolcs-Szatmár-Bereg County Hospitals and University Teaching Hospital, Adult Infectious Diseases Department and Hepatology Center in Nyíregyháza.

Since 2017, I have been working at the Dél-Pest Centrum hospital - National Institute of Hematology and Infectious Diseases, Department of Infectious Diseases, HIV/Tropical Department. During this time, in 2018, I took the specialist exam in infectology, then in 2021, allergology and clinical immunology.

In 2023, I also obtained a tropical disease specialist exam.
Gorgas Tropical Medicine Course, Diploma in Tropical Medicine and Hygiene (DTMH), 2023

Philippine Tropical Medicine Course, Nagasaki University School of Tropical Medicine and Global Health, 2024 

Prices
Make an appointment

Publications

Publications:

  • Travel Medicine and Infectious Diseases

2024. (co-author): MPox across countries from Central and Eastern Europe – 2022 outbreak. Travel Medicine and Infectious Disease 59 (2024) 102719.10.1016/j.tmaid.2024.102719

  • New Microbes and New Infections

2022. (co-author): Features of Mpox infection: The analysis of the data submitted to the ID-IRI network. Int J Infect Dis (2022), 10.1016/j.ijid.2022.11.040

  • Geroscience

2022. (co-author): Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary. Geroscience. 2021 Oct;43(5):2205-2213. doi: 10.1007/s11357-021-00452-9. Epub 2021 Sep 3. PMID: 34476717; PMCID: PMC8413073.

  • Medical Weekly

2020. (co-author): Anti-cytokine therapy in novel coronavirus disease (COVID-19) – the first administration of tocilizumab in Hungary at a department of infectology. Doctor Hetil. 2020 Jun;161(26):1070-1077. 
doi: 10.1556/650.2020.31899.

  • Journal of Clinical Virology

2019. (co-author): Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – result of a multinational ID-IRI study. J Clin Virol. 2020 Jan;122:104213. 
doi:10.1016/j.jcv.2019.104213. Epub 2019 Nov 11.

Prices